Hearing Loss & Tinnitus Protection Protocol
Hearing Loss & Tinnitus Protection Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A protocol targeting cochlear hair cell preservation, auditory nerve neuroprotection, and inner ear mitochondrial health to slow age-related hearing decline and address noise-induced or idiopathic sensorineural hearing loss.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Hearing Loss & Tinnitus Protection Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing maintenance; reassess audiometry every 12 months
Target Audience
Adults 45+ with age-related hearing decline, noise-exposed workers, tinnitus sufferers, or history of ototoxic drug exposure
| Compound | Dose | Frequency |
|---|---|---|
| NAD+ NAD+/NMN: restores SIRT3 in cochlear mitochondria; prevents noise-induced hearing loss by reducing oxidative hair cell death; reverses age-related auditory decline in animal models | 500 mg NMN | Once daily oral |
| SS-31 (Elamipretide) SS-31: reduces mitochondrial ROS in stria vascularis; highest metabolic demand tissue in cochlea; protects against ischemia-induced inner ear injury | 2-5 mg | 3x/week SC |
| BPC-157 BPC-157: improves cochlear microvascular flow via NO; reduces ototoxicity from aminoglycosides and cisplatin; anti-inflammatory in inner ear | 250 mcg | Twice daily SC |
| Thymosin Beta-4 Thymosin Beta-4: activates Wnt/Atoh1 hair cell differentiation pathway; promotes spiral ganglion neuron survival; angiogenic support for cochlear vasculature | 1-2 mg | Daily SC |
| GHK-Cu GHK-Cu: upregulates BDNF and NT-3 expression in auditory system; supports auditory nerve myelination and hair cell support cell function | 1-2 mg | 5x/week SC |
| Humanin Humanin: protects spiral ganglion neurons from oxidative and amyloid-mediated apoptosis; circulating levels decline with aging audiometric decline | 2-4 mg | Daily SC |
Free Peptide Guide
Hearing Loss & Tinnitus Protection Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned NAD+ timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Hearing Loss & Tinnitus Protection Protocol run before reassessment?
A common window is Ongoing maintenance; reassess audiometry every 12 months, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with NAD+ + SS-31 (Elamipretide) execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Sensorineural hearing loss is driven by irreversible cochlear hair cell death, stria vascularis degeneration, and spiral ganglion neuron loss — all processes rooted in mitochondrial ROS accumulation and energy failure. NAD+ via NMN restores SIRT3 activity in cochlear hair cell mitochondria, shown to prevent noise-induced hearing loss in animal models. SS-31 reduces mitochondrial ROS in the stria vascularis, which has the highest metabolic demand of any epithelium. BPC-157 improves cochlear blood flow through NO pathway upregulation and reduces ototoxicity from aminoglycosides or cisplatin. Thymosin Beta-4 stimulates the molecular pathways of hair cell differentiation and regeneration. GHK-Cu supports neurotrophic factor expression in the auditory system. Humanin protects spiral ganglion neurons — the auditory nerve cells — from oxidative apoptosis.
Clinical Research
No clinical references were provided for this stack yet.
More General Wellness Stacks
Altitude & Mountaineering Performance Protocol
A protocol for mountaineers, altitude athletes, and competitive cyclists targeting improved hypoxic adaptation, pulmonary vasodilation to prevent HAPE, enhanced oxygen utilization efficiency, and accelerated recovery from altitude-induced tissue stress.
COPD & Pulmonary Rehabilitation Protocol
An adjunctive protocol for individuals with COPD and other chronic lung diseases targeting the airway inflammation, pulmonary fibrosis, mucociliary dysfunction, and systemic muscle wasting that drive progressive respiratory decline.
Chronic Kidney Disease (CKD) Support Protocol
A nephroprotective protocol for patients with CKD stages 2–4, addressing progressive renal inflammation, anemia, muscle wasting (sarcopenia), peripheral neuropathy, and immune suppression through carefully selected peptides with renal safety profiles.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Hearing Loss & Tinnitus Protection Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.